RxDoctor Payments DataLook up a doctor →

Kristen Burgess

Nurse Practitioner · Zanesville, OHNPI 1407042468

Payments from drug & device makers

$9,792in general payments, 2019–2025

Across 656 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Boehringer Ingelheim$582
  • GSK$430
  • Pfizer$425
  • Amgen$412
  • plus $4K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)183$2,377
AstraZeneca(2 entities)78$1,283
Boehringer Ingelheim42$582
GSK30$430
Pfizer34$425
Amgen33$412
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$375
Lilly USA, LLC25$364
Exact Sciences17$331
Lundbeck LLC14$248
Merck18$238
Astellas Pharma US Inc11$237
Otsuka America Pharmaceutical, Inc.10$190
Bayer11$184
Novo Nordisk12$173
Phathom Pharmaceuticals, Inc.10$166
Johnson & Johnson11$154
Takeda Pharmaceuticals U.S.A., Inc.10$153
Daiichi Sankyo Inc.8$108
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$104
Sumitomo Pharma America, Inc.5$99
Sanofi-aventis U.S. LLC7$88
Medtronic3$85
Radius Health, Inc.4$84
Novartis5$78
Edwards Lifesciences3$71
Mylan Specialty L.p.3$57
E.r. Squibb & Sons, L.L.C.4$57
IBSA Pharma Inc.3$46
Seqirus USA Inc2$43
Dexcom, Inc.2$40
Axsome Therapeutics, Inc.2$39
Abbott2$38
Kowa Pharmaceuticals America, Inc.3$36
Biohaven Pharmaceutical Holding Company Ltd.2$31
Urovant Sciences Inc2$30
Boston Scientific1$30
Teva Pharmaceuticals USA, Inc.2$27
Jazz Pharmaceuticals Inc.2$25
Abiomed1$20
Alkermes, Inc.1$16
Grifols USA, LLC1$16
Biohaven Pharmaceuticals, Inc.1$16
Paratek Pharmaceuticals, Inc.1$16
Vivus LLC1$15
Shield Therapeutics Inc1$15
Esperion Therapeutics, Inc.1$15
Corcept Therapeutics1$15
Vivaquant Inc, Dba Rhythm Express1$14
Xeris Pharmaceuticals, Inc.1$14
Clarus Therapeutics Inc.1$13
Lucid Diagnostics Inc.1$13
Genentech USA, Inc.2$13
Avanir Pharmaceuticals, Inc.1$13
Philips North America LLC1$12
Hologic Sales And Service, LLC1$12
Organon1$11

How this compares

$9,792 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio →

Medicare billing

Part B allowed, 2024
$42,932
Medicare patients
117
Services billed
765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Zanesville

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →